Background: Prevention of mother-to-child transmission (PMTCT) programs have been
largely scaled-up, but data on infant HIV drug resistance from PMTCT programs …

Background: The main objective of this study was to determine the frequency and patterns of
HIV drug resistance–associated mutations among children under 18 months of age born to …

Background: In the era of more efficacious prevention of mother-to-child transmission
(PMTCT) regimens, documenting the profile of drug resistance in HIV-infected infants and …

Objectives To assess the prevalence and patterns of pre-treatment HIV drug resistance
(PDR) and HIV-1 subtype in infants from Argentina with exposure to different antiretroviral …

Background: WHO recommends protease-inhibitor-based first-line regimen in infants
because of risk of drug resistance from failed prophylaxis used in prevention of mother-to …

Objectives: The objectives of this study were to determine HIV drug resistance (HIVDR)
prevalence in Zambian infants upon diagnosis, and to determine how changing prevention …

Objectives With the advent of combined antiretroviral therapy (cART), perinatally HIV‐
infected children are surviving into adolescence and beyond. However, drug resistance …

Increased use of nonnucleoside reverse transcriptase inhibitors (NNRTIs) in pregnant and
breastfeeding women will result in fewer children infected with human immunodeficiency …

Background: Children have an augmented risk of pretreatment HIV drug resistance (PDR)
due to exposure to antiretroviral drugs for the prevention of mother-to-child transmission …

Background Programs for the prevention of mother-to-child transmission (PMTCT) of human
immunodeficiency virus (HIV) have been scaled up in many low-and middle-income …